We are live on
!
Find out more
United Therapeutics
UTHR
UTHR
475 hedge funds and large institutions have $9.94B invested in United Therapeutics in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 192 increasing their positions, 161 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more call options, than puts
Call options by funds: $22.4M | Put options by funds: $17.2M
19% more repeat investments, than reductions
Existing positions increased: 192 | Existing positions reduced: 161
2% less capital invested
Capital invested by funds: $10.1B → $9.94B (-$195M)
2.48% less ownership
Funds ownership: 98.65% → 96.18% (-2.5%)
6% less funds holding
Funds holding: 506 → 475 (-31)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
39% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 74
Holders
475
Holders Change
-31
Holders Change %
-6.13%
% of All Funds
7.46%
Holding in Top 10
14
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-17.65%
% of All Funds
0.22%
New
45
Increased
192
Reduced
161
Closed
74
Calls
$22.4M
Puts
$17.2M
Net Calls
+$5.14M
Net Calls Change
+$7.57M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$201M |
| 2 |
O
OrbiMed
New York
|
+$89M |
| 3 |
BlackRock
New York
|
+$76.4M |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$44.3M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$30.4M |
